<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T11:12:18Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/56823" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/56823</identifier><datestamp>2026-05-15T19:48:21Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Wang, Lihua</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair">Shen, Xiling</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair">Ma, Minglin</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Grimson, Andrew William</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Weiss, Robert S.</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2018-04-26T14:16:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2018-04-26T14:16:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2017-08-30</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 10380</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 10605823</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/56823</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/X4GB227S</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">10361500</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Colorectal cancer (CRC) is a leading cause of cancer related death. Colon cancer stem cells (CCSCs) play important roles in CRC tumorigenesis and metastasis. The role of non-coding RNAs such as microRNAs and long non-coding RNAs (lncRNAs) in regulating cancer progression and stem cell renewal and differentiation are being increasingly appreciated. The aim of my study is to understand how non-coding RNAs regulate CRC initiation and metastasis. 
In Chapter 1, we identified that Lnc34a, a previously unidentified LncRNA, is enriched in CCSCs to create a spatial imbalance in microRNA miR-34a expression, leading to the initiation of asymmetric cell division. Lnc34a recruits Dnmt3a via PHB2 and HDAC1 to methylate and deacetylate the miR-34a promoter simultaneously, hence epigenetically silencing miR-34a expression independent of its upstream regulator p53. Lnc34a levels affect CCSC self-renewal and colorectal cancer (CRC) growth in xenograft models. Lnc34a is upregulated in late-stage CRCs, contributing to epigenetic miR-34a silencing and CRC proliferation.
In Chapter 2, we describe that miR-34a regulates asymmetric division of normal intestinal stem cells (ISCs). Proinflammatory stress triggers asymmetric division of ISCs that normally undergo symmetric division. Silencing of miR-34a in ISCs inhibits asymmetric division and increases inflammation-induced ISC proliferation. These findings suggest that miR-34a provides a safeguard mechanism against excessive stem cell proliferation under inflammation, which is common during tumorigenesis.
In Chapter 3, we demonstrate that miR-34a deficiency leads to colon tumorigenesis after Citrobacter rodentium infection. miR-34a targets both immune and epithelial cells to restrain inflammation-induced reparative regeneration. miR-34a targets the Interleukin 6 receptor (IL-6R) to suppress T helper 17 (Th17) cell differentiation, targets the Interleukin 23 receptor (IL-23R) to block Th17 cell expansion, targets chemokine CCL22 production to hinder Th17 cell recruitment to the colon epithelium, and targets the Interleukin 17 receptor D (IL17RD) in colon stem cells to inhibit IL17-induced stem cell proliferation. This study highlights the importance of microRNAs in protecting tissue integrity during pro-inflammatory response despite their lack of function in regular tissue homeostasis.
In Chapter 4, we show that the microRNA miR-1269a promotes CRC metastasis and forms a positive feedback loop with TGF-β signaling. miR-1269a is upregulated in late-stage CRCs and strongly associated with risk of CRC relapse and metastasis. Consistent with clinical observations, miR-1269a significantly increases the ability of CRC cells to invade and metastasize in vivo. TGF-β activates miR-1269 via Sox4, while miR-1269a enhances TGF-β signaling by targeting Smad7 and HOXD10, hence forming a positive feedback loop to promote metastasis. Stage II CRC patients with high miR-1269a expression in resected tumors have significantly higher rate of relapse and worse prognosis. Our findings suggest that miR-1269a is a potential marker to guide adjuvant chemotherapy decisions for CRC patients and a potential therapeutic target to deter metastasis.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="subject">Cellular biology</dim:field>
   <dim:field mdschema="dc" element="subject">colon cancer</dim:field>
   <dim:field mdschema="dc" element="subject">lnc34a</dim:field>
   <dim:field mdschema="dc" element="subject">miR-1269</dim:field>
   <dim:field mdschema="dc" element="subject">miR-34a</dim:field>
   <dim:field mdschema="dc" element="subject">non-coding RNA</dim:field>
   <dim:field mdschema="dc" element="subject">Biology</dim:field>
   <dim:field mdschema="dc" element="subject">Stem Cell</dim:field>
   <dim:field mdschema="dc" element="subject">Biomedical engineering</dim:field>
   <dim:field mdschema="dc" element="title">NON-CODING RNA REGULATION OF COLON CANCER STEM CELL FATE AND METASTASIS</dim:field>
   <dim:field mdschema="dc" element="type">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Biological and Environmental Engineering</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Biological and Environmental Engineering</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://cornell-ecommons.eks.prod.4science.cloud/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Wang, Lihua</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="ab579e74-53ac-4197-9ba7-f2ce43cdd1aa">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en_US&lt;/Language>
   	&lt;Title>NON-CODING RNA REGULATION OF COLON CANCER STEM CELL FATE AND METASTASIS&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2017-08-30&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/X4GB227S&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Wang, Lihua&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;Keyword>Cellular biology&lt;/Keyword>
    &lt;Keyword>colon cancer&lt;/Keyword>
    &lt;Keyword>lnc34a&lt;/Keyword>
    &lt;Keyword>miR-1269&lt;/Keyword>
    &lt;Keyword>miR-34a&lt;/Keyword>
    &lt;Keyword>non-coding RNA&lt;/Keyword>
    &lt;Keyword>Biology&lt;/Keyword>
    &lt;Keyword>Stem Cell&lt;/Keyword>
    &lt;Keyword>Biomedical engineering&lt;/Keyword>
   	&lt;Abstract>Colorectal cancer (CRC) is a leading cause of cancer related death. Colon cancer stem cells (CCSCs) play important roles in CRC tumorigenesis and metastasis. The role of non-coding RNAs such as microRNAs and long non-coding RNAs (lncRNAs) in regulating cancer progression and stem cell renewal and differentiation are being increasingly appreciated. The aim of my study is to understand how non-coding RNAs regulate CRC initiation and metastasis. 
In Chapter 1, we identified that Lnc34a, a previously unidentified LncRNA, is enriched in CCSCs to create a spatial imbalance in microRNA miR-34a expression, leading to the initiation of asymmetric cell division. Lnc34a recruits Dnmt3a via PHB2 and HDAC1 to methylate and deacetylate the miR-34a promoter simultaneously, hence epigenetically silencing miR-34a expression independent of its upstream regulator p53. Lnc34a levels affect CCSC self-renewal and colorectal cancer (CRC) growth in xenograft models. Lnc34a is upregulated in late-stage CRCs, contributing to epigenetic miR-34a silencing and CRC proliferation.
In Chapter 2, we describe that miR-34a regulates asymmetric division of normal intestinal stem cells (ISCs). Proinflammatory stress triggers asymmetric division of ISCs that normally undergo symmetric division. Silencing of miR-34a in ISCs inhibits asymmetric division and increases inflammation-induced ISC proliferation. These findings suggest that miR-34a provides a safeguard mechanism against excessive stem cell proliferation under inflammation, which is common during tumorigenesis.
In Chapter 3, we demonstrate that miR-34a deficiency leads to colon tumorigenesis after Citrobacter rodentium infection. miR-34a targets both immune and epithelial cells to restrain inflammation-induced reparative regeneration. miR-34a targets the Interleukin 6 receptor (IL-6R) to suppress T helper 17 (Th17) cell differentiation, targets the Interleukin 23 receptor (IL-23R) to block Th17 cell expansion, targets chemokine CCL22 production to hinder Th17 cell recruitment to the colon epithelium, and targets the Interleukin 17 receptor D (IL17RD) in colon stem cells to inhibit IL17-induced stem cell proliferation. This study highlights the importance of microRNAs in protecting tissue integrity during pro-inflammatory response despite their lack of function in regular tissue homeostasis.
In Chapter 4, we show that the microRNA miR-1269a promotes CRC metastasis and forms a positive feedback loop with TGF-β signaling. miR-1269a is upregulated in late-stage CRCs and strongly associated with risk of CRC relapse and metastasis. Consistent with clinical observations, miR-1269a significantly increases the ability of CRC cells to invade and metastasize in vivo. TGF-β activates miR-1269 via Sox4, while miR-1269a enhances TGF-β signaling by targeting Smad7 and HOXD10, hence forming a positive feedback loop to promote metastasis. Stage II CRC patients with high miR-1269a expression in resected tumors have significantly higher rate of relapse and worse prognosis. Our findings suggest that miR-1269a is a potential marker to guide adjuvant chemotherapy decisions for CRC patients and a potential therapeutic target to deter metastasis.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>